- Home
- ISRG vs PFE Comparison
ISRG vs PFE Comparison
Compare ISRG & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRG
- PFE
- Stock Information
- Founded
- ISRG 1995
- PFE 1849
- Country
- ISRG United States
- PFE United States
- Employees
- ISRG N/A
- PFE N/A
- Industry
- ISRG Medical/Dental Instruments
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- ISRG Health Care
- PFE Health Care
- Exchange
- ISRG Nasdaq
- PFE Nasdaq
- Market Cap
- ISRG 167.4B
- PFE 140.8B
- IPO Year
- ISRG 2000
- PFE N/A
- Fundamental
- Price
- ISRG $441.16
- PFE $26.23
- Analyst Decision
- ISRG Buy
- PFE Hold
- Analyst Count
- ISRG 16
- PFE 12
- Target Price
- ISRG $595.87
- PFE $29.55
- AVG Volume (30 Days)
- ISRG 2.4M
- PFE 63.4M
- Earning Date
- ISRG 10-21-2025
- PFE 11-04-2025
- Dividend Yield
- ISRG N/A
- PFE 6.55%
- EPS Growth
- ISRG 23.20
- PFE N/A
- EPS
- ISRG 7.17
- PFE 1.89
- Revenue
- ISRG $9,145,000,000.00
- PFE $63,833,000,000.00
- Revenue This Year
- ISRG $19.57
- PFE $0.39
- Revenue Next Year
- ISRG $14.45
- PFE N/A
- P/E Ratio
- ISRG $61.51
- PFE $13.87
- Revenue Growth
- ISRG 20.77
- PFE 13.53
- 52 Week Low
- ISRG $425.00
- PFE $20.92
- 52 Week High
- ISRG $616.00
- PFE $30.43
- Technical
- Relative Strength Index (RSI)
- ISRG 43.16
- PFE 60.70
- Support Level
- ISRG $430.38
- PFE $23.59
- Resistance Level
- ISRG $459.81
- PFE $27.69
- Average True Range (ATR)
- ISRG 9.40
- PFE 0.67
- MACD
- ISRG 2.11
- PFE 0.30
- Stochastic Oscillator
- ISRG 36.03
- PFE 65.53
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.